Delivery Order SPE2DB20D1004-SPE2DB22FE9K7

Award Date 12/1/21
Potential Completion Date 12/2/21
Potential Value $3.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,507.33, is for the delivery of Metoprolol Succinate Extended-Release 100 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award, valued at $2,508.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,323,931 units of Metoprolol Succinate Extended-Release 25 mg tablets. The award has an ultimate completion date of January 16, 2024 and is a firm fixed-price delivery order contract. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.29 firm fixed price delivery order covers the supply of 4,558,966,079 units of the prescription medication Metoprolol Succinate Extended-Release 100 mg tablets. The award has an ultimate completion date of November 3, 2022 and was made on November 2, 2022. This delivery order is part of Amerisourcebergen's...
This federal contract award, valued at $1,503.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,683,361 units of Metoprolol Succinate Extended-Release 100 mg tablets. This is a firm-fixed price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of essential medical...
This federal contract award, valued at $1,298.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Metoprolol Succinate Extended-Release tablets in quantities of 1,000. This is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,976.48 firm fixed-price delivery order is for the supply of Metoprolol Succinate Extended-Release 100 mg tablets. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,498.60 firm fixed-price delivery order is for the supply of 4,566,566,344 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.13 firm fixed price delivery order is for the supply of Metoprolol Succinate Extended-Release 100 mg tablets in quantities of 1,000. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $3,085.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order contract for the supply of Metoprolol Succinate Extended-Release 50 mg tablets. The contract has a period of performance through January 4, 2024 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.41 firm-fixed-price delivery order is for the supply of 4,562,700 units of Metoprolol Succinate Extended-Release 50 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FE9K7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,245.04, is for the delivery of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 2, 2021.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation. These IDCs, valued at up to $999,999,999.00 and $750,000.00 respectively, enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 2/27/25, 10:12 AM